stomach cancer

After metastatic disease win, Merck's Keytruda flunks trial in early stomach cancer
Fierce Pharma
Tue, 06/20/23 - 09:39 pm
Merck
Keytruda
stomach cancer
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Fierce Pharma
Thu, 02/16/23 - 04:54 pm
Merck
Keytruda
clinical trials
stomach cancer
Deciphera details stomach cancer flop against Pfizer’s Sutent, cracking the door open for off-label use
Fierce Pharma
Tue, 01/25/22 - 11:28 pm
Deciphera Pharma
Qinlock
stomach cancer
Sutent
SeaGen builds cancer drug pipeline with China biotech deal
BioPharma Dive
Mon, 08/9/21 - 11:47 pm
Seagen
China
breast cancer
bladder cancer
stomach cancer
RemeGen
Imugene HER2 vaccine hits target in stomach cancer trial
Pharmaforum
Tue, 07/6/21 - 10:46 am
Imugene
cancer of the gastro-esophageal junction
stomach cancer
vaccines
clinical trials
HER-Vaxx
Merck to withdraw dangling accelerated approval for Keytruda in third-line stomach cancer
Endpoints
Thu, 07/1/21 - 11:09 pm
Merck
Keytruda
oncology
stomach cancer
FDA
Keytruda should lose stomach cancer indication, says ODAC
Pharmaforum
Fri, 04/30/21 - 11:09 am
Merck
Keytruda
ODAC
gastric cancer
stomach cancer
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
Mon, 01/18/21 - 01:15 pm
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
Roche
Herceptin
Why Five Prime Therapeutics Stock Gained 312% in November
Motley Fool
Tue, 12/8/20 - 10:46 am
Five Prime Therapeutics
stomach cancer
bemarituzumab
Five Prime looks to turn a corner
EP Vantage
Wed, 11/11/20 - 10:55 am
Five Prime Therapeutics
stomach cancer
bemarituzumab
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Sat, 05/30/20 - 08:04 pm
Daiichi Sankyo
AstraZeneca
Enhertu
stomach cancer
colorectal cancer
lung cancer
ASCO 2020
Blueprint gets first approval as FDA backs stomach cancer drug
Pharmaforum
Fri, 01/10/20 - 10:20 am
Blueprint Medicines
FDA
Ayvakit
stomach cancer
One of Merck’s pivotal stomach cancer trials for Keytruda flops, just months after an FDA OK
Endpoints
Thu, 12/14/17 - 09:25 pm
Merck
Keytruda
stomach cancer
clinical trials
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results
Xconomy
Mon, 12/11/17 - 11:18 pm
Eli Lilly
stomach cancer
Cyramza
Merck's Keytruda resumes regulatory hot streak with stomach cancer approval
Fierce Pharma
Mon, 09/25/17 - 07:28 pm
Merck
Keytruda
stomach cancer
Bristol-Myers' Opdivo succeeds in key stomach cancer study
Yahoo/Reuters
Thu, 11/10/16 - 11:02 am
Bristol-Myers Squibb
Opdivo
stomach cancer
A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
Forbes
Mon, 06/20/16 - 10:18 am
ASCO 2016
Claudiximab
antibodies
Ganymed
stomach cancer
esophageal cancer
Amgen scraps trials of drug for advanced stomach cancer
Yahoo/Reuters
Mon, 11/24/14 - 10:15 am
Amgen
stomach cancer
rilotumumab
Lilly gains new stomach cancer approval for Cyramza
Pharmaphorum
Thu, 11/6/14 - 09:41 am
Eli Lilly
stomach cancer
Cyramza
FDA
Merck KGaA Says Erbitux Fails In Stomach Cancer Trial
Bloomberg
Thu, 07/5/12 - 12:51 pm
Erbitux
stomach cancer
Merck KGaA

Pages